Affimed N.V. (AFMD)
NASDAQ: AFMD · Real-Time Price · USD
2.720
-0.280 (-9.33%)
At close: Nov 20, 2024, 4:00 PM
2.700
-0.020 (-0.74%)
Pre-market: Nov 21, 2024, 6:13 AM EST

Affimed Revenue

Affimed had revenue of 164.00K EUR in the quarter ending September 30, 2024, a decrease of -91.62%. This brings the company's revenue in the last twelve months to 5.64M, down -72.92% year-over-year. In the year 2023, Affimed had annual revenue of 13.91M, down -67.39%.

Revenue (ttm)
5.64M EUR
Revenue Growth
-72.92%
P/S Ratio
6.66
Revenue / Employee
74,171 EUR
Employees
76
Market Cap
42.65M USD

Revenue Chart

* This company reports financials in EUR.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202313.91M-28.76M-67.39%
Dec 31, 202242.67M1.12M2.70%
Dec 31, 202141.55M12.69M43.99%
Dec 31, 202028.86M7.43M34.66%
Dec 31, 201921.43M-2.30M-9.68%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Cytosorbents 37.74M
BGM Group 29.87M
Kronos Bio 9.87M
Milestone Scientific 8.88M
Lucid Diagnostics 4.19M
vTv Therapeutics 1.00M
CollPlant Biotechnologies 689.00K
Revenue Rankings